In summary, TDG interacts with DNMT3A to promote ubiquitination degradation, induces the hypomethylation of the TIMP2 promoter, increases TIMP2 expression, and significantly inhibits the migration and invasion abilities of human colon cancer cells (Figure 7). The gene discussed is DNMT3A; the disease is malignant colon neoplasm.